These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 17383428

  • 1. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF, Wong BC.
    Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
    [Abstract] [Full Text] [Related]

  • 2. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
    Li M, Wang J, Ng SS, Chan CY, Chen AC, Xia HP, Yew DT, Wong BC, Chen Z, Kung HF, Lin MC.
    Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
    [Abstract] [Full Text] [Related]

  • 3. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
    Zhuang ZH, Tsao SW, Deng W, Wang JD, Xia HH, He H, Feng HC, Wang LD, Gu Q, Lam SK, Lin MC, Kung HF, Wong BC.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
    [Abstract] [Full Text] [Related]

  • 4. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
    Kunze D, Wuttig D, Kausch I, Blietz C, Blumhoff L, Burmeister Y, Kraemer K, Fuessel S, Toma M, Schwenzer B, Meye A, Grimm MO, Hakenberg OW, Jocham D, Wirth MP.
    Int J Oncol; 2008 May; 32(5):1049-56. PubMed ID: 18425331
    [Abstract] [Full Text] [Related]

  • 5. XIAP-associated factor 1 interacts with and attenuates the trans-activity of four and a Half LIM protein 2.
    Zhang W, Yang Y, Jiang B, Peng J, Tu S, Sardet C, Zhang Y, Pang R, Hung IF, Tan VP, Lam CS, Wang J, Wong BC.
    Mol Carcinog; 2011 Mar; 50(3):199-207. PubMed ID: 21104993
    [Abstract] [Full Text] [Related]

  • 6. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP.
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [Abstract] [Full Text] [Related]

  • 7. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
    Zhang W, Jiang B, Guo Z, Sardet C, Zou B, Lam CS, Li J, He M, Lan HY, Pang R, Hung IF, Tan VP, Wang J, Wong BC.
    Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K, Kawamata H, Hino S, Uchida D, Miwa Y, Hamano H, Omotehara F, Yoshida H, Sato M.
    Cancer Res; 1998 Feb 01; 58(3):549-55. PubMed ID: 9458104
    [Abstract] [Full Text] [Related]

  • 9. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF, Bai S, Uthgenannt BA, Halstead LR, McLoughlin P, Schafer BW, Chu PH, Chen J, Otey CA, Cao X, Cheng SL.
    J Bone Miner Res; 2006 Jan 01; 21(1):17-28. PubMed ID: 16355270
    [Abstract] [Full Text] [Related]

  • 10. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
    Schwartz B, Melnikova VO, Tellez C, Mourad-Zeidan A, Blehm K, Zhao YJ, McCarty M, Adam L, Bar-Eli M.
    Oncogene; 2007 Jun 14; 26(28):4049-58. PubMed ID: 17224907
    [Abstract] [Full Text] [Related]

  • 11. [Construction of a gastric cancer related gene GCRG213-specific siRNA expression vector and its effect on gastric cancer cells in vitro].
    Gao LL, Wu BY, Wang MW, Zhan DW, Zhang L, You WD, Wang WH.
    Zhonghua Zhong Liu Za Zhi; 2007 Feb 14; 29(2):84-8. PubMed ID: 17645837
    [Abstract] [Full Text] [Related]

  • 12. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C, Hasegawa K, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yazumi S, Yamagishi H, Okanoue T, Chiba T, Hagiwara A.
    Clin Cancer Res; 2005 Sep 15; 11(18):6479-88. PubMed ID: 16166423
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA.
    Hao JH, Gu QL, Liu BY, Li JF, Chen XH, Ji YB, Zhu ZG, Lin YZ.
    Chin Med J (Engl); 2007 Dec 05; 120(23):2105-11. PubMed ID: 18167184
    [Abstract] [Full Text] [Related]

  • 14. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
    Kleiber K, Strebhardt K, Martin BT.
    Anticancer Res; 2007 Dec 05; 27(1A):55-61. PubMed ID: 17352216
    [Abstract] [Full Text] [Related]

  • 15. [Effects of antisense 6 gene on colon cancer cells].
    Zhang ZY, Xu KS, Yang GY, Wang JS, Gao Y, Liu YF, Shuai J, Wang JY, Li SY, Shou NH, Niu J.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 09; 87(37):2645-8. PubMed ID: 18162155
    [Abstract] [Full Text] [Related]

  • 16. FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29.
    Amann T, Egle Y, Bosserhoff AK, Hellerbrand C.
    Oncol Rep; 2010 Jun 09; 23(6):1669-74. PubMed ID: 20428824
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
    Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, Kawaguchi Y, Fujimoto K, Wada M, Miyatake S, Imamura M.
    Surgery; 2005 Aug 09; 138(2):299-305. PubMed ID: 16153440
    [Abstract] [Full Text] [Related]

  • 18. [The effect of calcyclin binding protein on gastric cancer cell proliferation].
    Ning XX, Sun SR, Li Y, Gong WQ, Liu LL, Sun L, Liang J, Pan YL, Cheng Y, Wu KC, Fan DM.
    Zhonghua Yi Xue Za Zhi; 2006 Dec 12; 86(46):3264-8. PubMed ID: 17313807
    [Abstract] [Full Text] [Related]

  • 19. A novel colon cancer gene therapy using rAAV‑mediated expression of human shRNA-FHL2.
    Wu Y, Guo Z, Zhang D, Zhang W, Yan Q, Shi X, Zhang M, Zhao Y, Zhang Y, Jiang B, Cheng T, Bai Y, Wang J.
    Int J Oncol; 2013 Nov 12; 43(5):1618-26. PubMed ID: 24008552
    [Abstract] [Full Text] [Related]

  • 20. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
    Zhang PH, Zou L, Tu ZG.
    J Surg Res; 2006 Mar 12; 131(1):143-9. PubMed ID: 16298398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.